Noah Jones
Mount Carmel Health
7 Papers
Noah Jones is an academic researcher from Mount Carmel Health. The author has contributed to research in topics: Mitral valve replacement & Internal medicine. The author has an hindex of 5, co-authored 5 publications.
Chat about Author
Papers
A Prospective, Single-Arm, Multicenter Trial of Ultrasound-Facilitated, Catheter-Directed, Low-Dose Fibrinolysis for Acute Massive and Submassive Pulmonary Embolism: The SEATTLE II Study.
Gregory Piazza,Benjamin Hohlfelder,Michael R. Jaff,Kenneth Ouriel,Tod C. Engelhardt,Keith M. Sterling,Noah Jones,John C. Gurley,Rohit Bhatheja,Robert J. Kennedy,Nilesh J. Goswami,Kannan Natarajan,John H. Rundback,Immad Sadiq,Stephen K. Liu,Narinder Bhalla,M. Laiq Raja,Barry S. Weinstock,Jacob Cynamon,Fakhir Elmasri,Mark J. Garcia,Mark H. Kumar,Juan Ayerdi,Peter A. Soukas,William T. Kuo,Ping-Yu Liu,Samuel Z. Goldhaber,Seattle Ii Investigators +27 more
TL;DR: Ultrasound-facilitated, catheter-directed, low-dose fibrinolysis decreased RV dilation, reduced pulmonary hypertension, decreased anatomic thrombus burden, and minimized intracranial hemorrhage in patients with acute massive and submassive PE.
795
A Randomized Trial of the Optimum Duration of Acoustic Pulse Thrombolysis Procedure in Acute Intermediate-Risk Pulmonary Embolism: The OPTALYSE PE Trial
Victor F. Tapson,Keith M. Sterling,Noah Jones,Mahir Elder,Uttam Tripathy,J. Brower,Robert Maholic,Charles B. Ross,Kannan Natarajan,Pete Fong,Lee Greenspon,Houman Tamaddon,Amir R. Piracha,Tod C. Engelhardt,John N. Katopodis,Vasco Marques,Andrew S.P. Sharp,Gregory Piazza,Samuel Z. Goldhaber +18 more
TL;DR: Treatment with USCDT using a shorter delivery duration and lower-dose tPA was associated with improved right ventricular function and reduced clot burden compared with baseline, and improvement in refined modified Miller score was seen in all groups.
388
1-Year Outcomes of Transcatheter Mitral Valve Replacement in Patients With Severe Mitral Annular Calcification
Mayra Guerrero,Marina Urena,Dominique Himbert,Dee Dee Wang,Mackram F. Eleid,Susheel Kodali,Isaac George,Tarun Chakravarty,Moses Mathur,David Holzhey,Ashish Pershad,H. Kenith Fang,Daniel O'Hair,Noah Jones,Vaikom S. Mahadevan,Nicolas Dumonteil,Josep Rodés-Cabau,Nicolo Piazza,Enrico Ferrari,Daniel Ciaburri,Mohammed Nejjari,Augustin Delago,Paul Sorajja,Firas Zahr,Vivek Rajagopal,Brian Whisenant,Pinak B. Shah,Jan-Malte Sinning,Adam Witkowski,Hélène Eltchaninoff,Danny Dvir,Bena Martin,Guilherme F. Attizzani,Diego Felipe Gaia,Nagela S. V. Nunes,Amir-Ali Fassa,Faraz Kerendi,Gregory Pavlides,Vijay Iyer,Georges Kaddissi,Christian Witzke,James Wudel,Gregory J. Mishkel,Bryan Raybuck,Chi Wang,Ron Waksman,Igor F. Palacios,Alain Cribier,John G. Webb,Vinnie Bapat,Mark Reisman,Raj Makkar,Martin B. Leon,Charanjit S. Rihal,Alec Vahanian,William W. O'Neill,Ted Feldman +56 more
TL;DR: The TMVR in MAC Global Registry as mentioned in this paper is a multicenter registry that collects data on outcomes of transcatheter mitral valve replacement in patients with severe mitral annular calcification.
327
Transcatheter mitral valve replacement after surgical repair or replacement comprehensive midterm evaluation of valve-in-valve and valve-in-ring implantation from the VIVID registry
Matheus Simonato,Brian Whisenant,Henrique Barbosa Ribeiro,John G. Webb,Ran Kornowski,Mayra Guerrero,Harindra C. Wijeysundera,Lars Søndergaard,Ole De Backer,Pedro A. Villablanca,Charanjit S. Rihal,Mackram F. Eleid,Jörg Kempfert,Axel Unbehaun,Magdalena Erlebach,Filip Casselman,Matti Adam,Matteo Montorfano,Marco Ancona,Francesco Saia,Timm Ubben,Felix Meincke,Massimo Napodano,Pablo Codner,Joachim Schofer,Marc P. Pelletier,Anson Cheung,Mony Shuvy,José Honório Palma,José Honório Palma,Diego Felipe Gaia,Alison Duncan,David Hildick-Smith,Verena Veulemans,Jan Malte Sinning,Yaron Arbel,Luca Testa,Arend de Weger,Hélène Eltchaninoff,Thibault Hemery,Uri Landes,Didier Tchetche,Nicolas Dumonteil,Josep Rodés-Cabau,Won-Keun Kim,Konstantinos Spargias,Panagiota Kourkoveli,Ori Ben-Yehuda,Rui Campante Teles,Marco Barbanti,Claudia Fiorina,Arun K. Thukkani,G. Burkhard Mackensen,Noah Jones,Patrizia Presbitero,Anna Sonia Petronio,Abdelhakim Allali,Didier Champagnac,Sabine Bleiziffer,Tanja K. Rudolph,Alessandro Iadanza,Stefano Salizzoni,Marco Agrifoglio,Luis Nombela-Franco,Nikolaos Bonaros,Malek Kass,Giuseppe Bruschi,Nicolas Amabile,Adnan K. Chhatriwalla,Antonio Messina,Sameer A. Hirji,Martin Andreas,Robert C. Welsh,Wolfgang Schoels,Farrel Hellig,Stephan Windecker,Stefan Stortecky,Francesco Maisano,Gregg W. Stone,Danny Dvir +79 more
TL;DR: Significant residual MS and/or MR were not infrequent after mitral ViV and ViR procedures and were both associated with a need for repeat valve replacement and strategies to improve postprocedural hemodynamics should be further explored.
Impact of Pre-Existing Prosthesis-Patient Mismatch on Survival Following Aortic Valve-in-Valve Procedures
Philippe Pibarot,Matheus Simonato,Marco Barbanti,Axel Linke,Ran Kornowski,Tanja K. Rudolph,Mark S. Spence,Neil Moat,Gabriel S. Aldea,Marco G. Mennuni,Alessandro Iadanza,Hafid Amrane,Diego Felipe Gaia,Won-Keun Kim,Massimo Napodano,Hardy Baumbach,Ariel Finkelstein,Junjiro Kobayashi,Stephen Brecker,Creighton W. Don,Alfredo Giuseppe Cerillo,Axel Unbehaun,David Attias,Mohammed Nejjari,Noah Jones,Claudia Fiorina,Didier Tchetche,Raphael Philippart,Konstantinos Spargias,José M. de la Torre Hernández,Azeem Latib,Danny Dvir +31 more
TL;DR: Pre-existing PPM of the failed surgical valve is strongly and independently associated with increased risk for mortality following ViV implantation.
115